PATENT CLAIM ANALYSIS

Application Number: 16008436
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-02
Patent Classification: ["546", "114000"]

Abstract:
Optically active 2-hydroxytetrahydrothienopyridine derivatives represented by Formula I and pharmaceutically acceptable salts, preparation method and use in the manufacture of a medicament thereof are disclosed. The pharmacodynamic experiment results show that the present compounds of Formula I are useful for inhibiting platelet aggregation. The pharmacokinetic experiment results show that the present compound of Formula I can be converted in vivo into pharmacologically active metabolites and are therefore useful for inhibiting platelet aggregation. Therefore, the present compounds are useful for the manufacture of a medicament for preventing or treating thrombosis and embolism related diseases.

Claim (Index 13):
A pharmaceutical composition comprising a compound of  claim 5  or a pharmaceutically acceptable salt thereof as an active ingredient, and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 94.0
- Lexical Diversity: 1.73684
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13576534', '15275967', '12421230', '11890211', '10576731']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7984772558376468
- 35 USC 102 Novelty (BERT): 0.5848520415080074
- Combined Prediction Score: 0.7771147344046829
- Mean Citation Score: 451.387536
- Max Citation Score: 574.82513
- Similarity Product: 384.71289432359566

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test